These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21374556)

  • 21. Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.
    Kianersi F; Naderi Beni A; Naderi Beni Z
    Int Ophthalmol; 2012 Dec; 32(6):539-45. PubMed ID: 22733253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
    Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
    Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis.
    de-la-Torre A; López-Castillo CA; Gómez-Marín JE
    Eye (Lond); 2009 May; 23(5):1090-3. PubMed ID: 18617902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pattern of toxoplasmic retinochoroiditis in a Spanish referral center.
    Rey A; Llorenç V; Pelegrín L; Mesquida M; Molins B; Rios J; Arévalo JF; Adán A
    Ophthalmologica; 2013; 229(3):173-8. PubMed ID: 23548496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.
    Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O
    Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional Differences in the Clinical Manifestation of Ocular Toxoplasmosis Between the Center and Northeast of Argentina.
    Schlaen A; Colombero D; Ormaechea S; Ladeveze E; Rudzinski C; Ingolotti M; Couto C; Rudzinski M
    Ocul Immunol Inflamm; 2019; 27(5):722-730. PubMed ID: 29953310
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ocular toxoplasmosis and toxocariasis in childhood].
    Deuter CM; Garweg JG; Pleyer U; Schönherr U; Thurau S
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):483-7. PubMed ID: 17594617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuban Ocular Toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba.
    Bustillo JL; Diaz JD; Pacheco IC; Gritz DC
    Br J Ophthalmol; 2015 Mar; 99(3):382-6. PubMed ID: 25253767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Ocular Toxoplasmosis in Three Community Surveys in the Central Region of Ghana, West Africa.
    Abu EK; Boampong JN; Amoabeng JK; Ilechie AA; Kyei S; Owusu-Ansah A; Boadi-Kusi SB; Amoani B; Ayi I
    Ophthalmic Epidemiol; 2016; 23(1):14-9. PubMed ID: 26786055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of uveitis in a referral hospital in Turkey.
    Çakar Özdal MP; Yazici A; Tüfek M; Öztürk F
    Turk J Med Sci; 2014; 44(2):337-42. PubMed ID: 25536746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination.
    Dodds EM; Holland GN; Stanford MR; Yu F; Siu WO; Shah KH; Ten Dam-van Loon N; Muccioli C; Hovakimyan A; Barisani-Asenbauer T;
    Am J Ophthalmol; 2008 Dec; 146(6):856-65.e2. PubMed ID: 19027421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.
    Vishnevskia-Dai V; Achiron A; Buhbut O; Berar OV; Musika AA; Elyashiv SM; Hecht I
    Int Ophthalmol; 2020 Apr; 40(4):811-821. PubMed ID: 31792847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak of acquired ocular toxoplasmosis involving 248 patients.
    Balasundaram MB; Andavar R; Palaniswamy M; Venkatapathy N
    Arch Ophthalmol; 2010 Jan; 128(1):28-32. PubMed ID: 20065213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of serological titres in the diagnosis of ocular toxoplasmosis.
    Roh M; Yasa C; Cho H; Nicholson L; Uchiyama E; Young LH; Lobo AM; Papaliodis GN; Durand ML; Sobrin L
    Acta Ophthalmol; 2016 Aug; 94(5):521-2. PubMed ID: 26426456
    [No Abstract]   [Full Text] [Related]  

  • 35. Optic nerve involvement in ocular toxoplasmosis: 12 year data from a tertiary referral center in Turkey.
    Simsek M; Ozdal PC; Kocer AM
    Arq Bras Oftalmol; 2019; 82(4):302-309. PubMed ID: 30970124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optic nerve changes in ocular toxoplasmosis.
    Eckert GU; Melamed J; Menegaz B
    Eye (Lond); 2007 Jun; 21(6):746-51. PubMed ID: 16575416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases.
    Suhardjo ; Utomo PT; Agni AN
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):291-7. PubMed ID: 12971552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics, visual acuity outcomes, and factors associated with loss of vision among patients with active ocular toxoplasmosis: A retrospective study in a Thai tertiary center.
    Sittivarakul W; Treerutpun W; Tungsattayathitthan U
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012232. PubMed ID: 38843299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of Epidemiology of Uveitis in Asia: Pattern of Uveitis in a Tertiary Hospital in the Philippines.
    Abaño JM; Galvante PR; Siopongco P; Dans K; Lopez J
    Ocul Immunol Inflamm; 2017; 25(sup1):S75-S80. PubMed ID: 29083984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical features of ocular toxoplasmosis in an inmigrant population in the Barcelona area: Study of 22 patients].
    Alvarez G; Rey A; Adán A
    Arch Soc Esp Oftalmol; 2010 Jun; 85(6):202-8. PubMed ID: 21074095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.